Annual D&A
$2.40 M
+$379.60 K+18.77%
December 31, 2023
Summary
- As of March 6, 2025, OPRX annual depreciation & amortization is $2.40 million, with the most recent change of +$379.60 thousand (+18.77%) on December 31, 2023.
- During the last 3 years, OPRX annual D&A has risen by +$430.50 thousand (+21.84%).
- OPRX annual D&A is now at all-time high.
Performance
OPRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.09 M
+$22.00 K+2.05%
September 30, 2024
Summary
- As of March 6, 2025, OPRX quarterly depreciation & amortization is $1.09 million, with the most recent change of +$22.00 thousand (+2.05%) on September 30, 2024.
- Over the past year, OPRX quarterly D&A has increased by +$629.00 thousand (+134.98%).
- OPRX quarterly D&A is now at all-time high.
Performance
OPRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$4.24 M
+$629.00 K+17.41%
September 30, 2024
Summary
- As of March 6, 2025, OPRX TTM depreciation & amortization is $4.24 million, with the most recent change of +$629.00 thousand (+17.41%) on September 30, 2024.
- Over the past year, OPRX TTM D&A has increased by +$2.39 million (+129.09%).
- OPRX TTM D&A is now at all-time high.
Performance
OPRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
OPRX Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +18.8% | +135.0% | +129.1% |
3 y3 years | +21.8% | +184.3% | +115.8% |
5 y5 years | +658.8% | +155.1% | +260.9% |
OPRX Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +22.2% | at high | +184.3% | at high | +129.1% |
5 y | 5-year | at high | +104.4% | at high | +184.3% | at high | +260.9% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
OptimizeRx Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $1.09 M(+2.1%) | $4.24 M(+17.4%) |
Jun 2024 | - | $1.07 M(+0.6%) | $3.61 M(+20.2%) |
Mar 2024 | - | $1.07 M(+6.0%) | $3.00 M(+25.1%) |
Dec 2023 | $2.40 M(+18.8%) | $1.01 M(+116.0%) | $2.40 M(+29.7%) |
Sep 2023 | - | $466.00 K(+0.2%) | $1.85 M(-2.6%) |
Jun 2023 | - | $465.00 K(+0.2%) | $1.90 M(-5.6%) |
Mar 2023 | - | $464.00 K(+1.6%) | $2.01 M(-0.4%) |
Dec 2022 | $2.02 M(+2.9%) | $456.50 K(-11.5%) | $2.02 M(+3.7%) |
Sep 2022 | - | $515.80 K(-10.8%) | $1.95 M(-0.5%) |
Jun 2022 | - | $578.10 K(+22.6%) | $1.96 M(+1.0%) |
Mar 2022 | - | $471.50 K(+22.4%) | $1.94 M(-1.3%) |
Dec 2021 | $1.97 M(-0.3%) | $385.20 K(-26.8%) | $1.97 M(-1.1%) |
Sep 2021 | - | $526.00 K(-5.7%) | $1.99 M(+0.1%) |
Jun 2021 | - | $557.80 K(+12.4%) | $1.98 M(+1.9%) |
Mar 2021 | - | $496.30 K(+21.9%) | $1.95 M(-1.2%) |
Dec 2020 | $1.97 M(+67.7%) | $407.20 K(-22.2%) | $1.97 M(-1.1%) |
Sep 2020 | - | $523.40 K(+0.5%) | $1.99 M(+11.4%) |
Jun 2020 | - | $520.80 K(+0.2%) | $1.79 M(+19.0%) |
Mar 2020 | - | $519.70 K(+21.1%) | $1.50 M(+28.0%) |
Dec 2019 | $1.18 M(+271.3%) | $429.20 K(+34.1%) | $1.18 M(+30.7%) |
Sep 2019 | - | $320.10 K(+35.9%) | $899.10 K(+41.9%) |
Jun 2019 | - | $235.60 K(+23.8%) | $633.50 K(+40.0%) |
Mar 2019 | - | $190.30 K(+24.3%) | $452.40 K(+42.9%) |
Dec 2018 | $316.50 K(-2.5%) | $153.10 K(+180.9%) | $316.60 K(+15.1%) |
Sep 2018 | - | $54.50 K(0.0%) | $275.10 K(-5.7%) |
Jun 2018 | - | $54.50 K(0.0%) | $291.60 K(-5.4%) |
Mar 2018 | - | $54.50 K(-51.2%) | $308.10 K(-5.1%) |
Dec 2017 | $324.60 K(+38.0%) | $111.60 K(+57.2%) | $324.60 K(+10.3%) |
Sep 2017 | - | $71.00 K(0.0%) | $294.30 K(+6.7%) |
Jun 2017 | - | $71.00 K(0.0%) | $275.90 K(+7.8%) |
Mar 2017 | - | $71.00 K(-12.7%) | $256.00 K(+8.8%) |
Dec 2016 | $235.30 K | $81.30 K(+54.6%) | $235.30 K(-4.3%) |
Sep 2016 | - | $52.60 K(+2.9%) | $245.90 K(-10.9%) |
Jun 2016 | - | $51.10 K(+1.6%) | $276.00 K(-9.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | $50.30 K(-45.3%) | $304.60 K(-8.8%) |
Dec 2015 | $334.00 K(+26.4%) | $91.90 K(+11.1%) | $334.00 K(+3.1%) |
Sep 2015 | - | $82.70 K(+3.8%) | $324.00 K(+5.2%) |
Jun 2015 | - | $79.70 K(0.0%) | $307.90 K(+8.0%) |
Mar 2015 | - | $79.70 K(-2.7%) | $285.10 K(+7.9%) |
Dec 2014 | $264.30 K(+36.4%) | $81.90 K(+23.0%) | $264.30 K(+14.1%) |
Sep 2014 | - | $66.60 K(+17.0%) | $231.60 K(+8.6%) |
Jun 2014 | - | $56.90 K(-3.4%) | $213.20 K(+4.3%) |
Mar 2014 | - | $58.90 K(+19.7%) | $204.50 K(+5.6%) |
Dec 2013 | $193.80 K(+3.6%) | $49.20 K(+2.1%) | $193.70 K(+1.1%) |
Sep 2013 | - | $48.20 K(0.0%) | $191.50 K(+0.8%) |
Jun 2013 | - | $48.20 K(+0.2%) | $190.00 K(+0.5%) |
Mar 2013 | - | $48.10 K(+2.3%) | $189.10 K(+1.1%) |
Dec 2012 | $187.10 K(+28.8%) | $47.00 K(+0.6%) | $187.00 K(-4.2%) |
Sep 2012 | - | $46.70 K(-1.3%) | $195.20 K(+9.4%) |
Jun 2012 | - | $47.30 K(+2.8%) | $178.50 K(+10.7%) |
Mar 2012 | - | $46.00 K(-16.7%) | $161.30 K(+10.9%) |
Dec 2011 | $145.30 K(+142.6%) | $55.20 K(+84.0%) | $145.40 K(+15.7%) |
Sep 2011 | - | $30.00 K(-0.3%) | $125.70 K(+21.0%) |
Jun 2011 | - | $30.10 K(0.0%) | $103.90 K(+26.9%) |
Mar 2011 | - | $30.10 K(-15.2%) | $81.90 K(+36.7%) |
Dec 2010 | $59.90 K(+84.3%) | $35.50 K(+332.9%) | $59.90 K(+84.3%) |
Sep 2010 | - | $8200.00(+1.2%) | $32.50 K(+0.3%) |
Jun 2010 | - | $8100.00(0.0%) | $32.40 K(0.0%) |
Mar 2010 | - | $8100.00(0.0%) | $32.40 K(0.0%) |
Dec 2009 | $32.50 K(+1.2%) | $8100.00(0.0%) | $32.40 K(+12.9%) |
Sep 2009 | - | $8100.00(0.0%) | $28.70 K(-4.0%) |
Jun 2009 | - | $8100.00(0.0%) | $29.90 K(-7.7%) |
Mar 2009 | - | $8100.00(+84.1%) | $32.40 K(+0.6%) |
Dec 2008 | $32.10 K(+1046.4%) | $4400.00(-52.7%) | $32.20 K(+15.8%) |
Sep 2008 | - | $9300.00(-12.3%) | $27.80 K(+50.3%) |
Jun 2008 | - | $10.60 K(+34.2%) | $18.50 K(+134.2%) |
Mar 2008 | - | $7900.00 | $7900.00 |
Dec 2007 | $2800.00 | - | - |
FAQ
- What is OptimizeRx annual depreciation & amortization?
- What is the all time high annual D&A for OptimizeRx?
- What is OptimizeRx annual D&A year-on-year change?
- What is OptimizeRx quarterly depreciation & amortization?
- What is the all time high quarterly D&A for OptimizeRx?
- What is OptimizeRx quarterly D&A year-on-year change?
- What is OptimizeRx TTM depreciation & amortization?
- What is the all time high TTM D&A for OptimizeRx?
- What is OptimizeRx TTM D&A year-on-year change?
What is OptimizeRx annual depreciation & amortization?
The current annual D&A of OPRX is $2.40 M
What is the all time high annual D&A for OptimizeRx?
OptimizeRx all-time high annual depreciation & amortization is $2.40 M
What is OptimizeRx annual D&A year-on-year change?
Over the past year, OPRX annual depreciation & amortization has changed by +$379.60 K (+18.77%)
What is OptimizeRx quarterly depreciation & amortization?
The current quarterly D&A of OPRX is $1.09 M
What is the all time high quarterly D&A for OptimizeRx?
OptimizeRx all-time high quarterly depreciation & amortization is $1.09 M
What is OptimizeRx quarterly D&A year-on-year change?
Over the past year, OPRX quarterly depreciation & amortization has changed by +$629.00 K (+134.98%)
What is OptimizeRx TTM depreciation & amortization?
The current TTM D&A of OPRX is $4.24 M
What is the all time high TTM D&A for OptimizeRx?
OptimizeRx all-time high TTM depreciation & amortization is $4.24 M
What is OptimizeRx TTM D&A year-on-year change?
Over the past year, OPRX TTM depreciation & amortization has changed by +$2.39 M (+129.09%)